# Renal Anhydramnios Fetal Therapy

> **NCT03101891** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 70 (estimated)

## Conditions studied

- Anhydramnios
- Potter Syndrome
- Lung Hypoplasia
- Multicystic Dysplastic Kidney
- Multicystic Renal Dysplasia, Bilateral
- Lower Urinary Tract Obstructive Syndrome
- Fetal Renal Anomaly

## Interventions

- **PROCEDURE:** Serial amnioinfusions with isotonic fluid
- **DEVICE:** Spinal needle
- **DRUG:** Isotonic fluid

## Key facts

- **NCT ID:** NCT03101891
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-12-21
- **Primary completion:** 2025-03-10
- **Final completion:** 2030-02-28
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03101891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03101891, "Renal Anhydramnios Fetal Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03101891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*